TOLREMO therapeutics Competitors and Similar CompaniesClear all
TOLREMO therapeutics's competitors and similar companies include Zymeworks, Gossamer Bio, JW Therapeutics and Neovii.
 TOLREMO therapeutics TOLREMO therapeutics is a company that aims to prevent resistance development in cancer. |  Zymeworks Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics. |  Gossamer Bio Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. |  Neovii Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
| ||
Founding Date | Founding Date 2017 | Founding Date 2003 | Founding Date 2015 | Founding Date 2016 | Founding Date 2003 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Muttenz, CH HQ | Locations Vancouver, CA HQ Seattle, US | Locations San Diego, US HQ Dublin 2, IE | Locations CN HQ Suzhou Shi, CN | Locations Rapperswil-Jona, CH HQ Gräfelfing, DE Lexington, US |
Employees | Employees 15 | Employees 45519% increase | Employees 11820% increase | Employees 106 | Employees 1193% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 973.3 m | Valuation ($) 208 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $106m (FY, 2025) | Revenue (est.) $48.5m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($81.1m) (FY, 2025) | Net income ($170.4m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 9.4m (almost 8 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 90m (over 8 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 11.9m | Total funding raised $ 125.9m | Total funding raised $ 480m | Total funding raised $ 90m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Zymeworks
HQ
Vancouver, CA
Employees
455↑ 19% increase
Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
View companyGossamer Bio
HQ
San Diego, US
Employees
118↑ 20% increase
Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations.
View company
JW Therapeutics
HQ
CN
Employees
106
JW Therapeutics is a biotech company focusing on clinical cell therapy technology.
View companyNeovii
HQ
Rapperswil-Jona, CH
Employees
119↑ 3% increase
Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
View company